Vishnu Chemicals Limited — PPTs, 18-11-2024: Investor Presentation

### Financial Highlights

In Q2 FY25, Vishnu Chemicals reported consolidated operating revenues of ₹343.8 Cr, up 12% YoY, alongside a gross profit of ₹147.0 Cr (6% increase). However, gross margins softened to 42.8% (from 45.2%). EBITDA slightly declined to ₹45.1 Cr, with a margin of 13.1%. Profit After Tax (PAT) was ₹22.8 Cr, down 5% YoY, reflecting margin pressures.

### Strategic Initiatives and Growth Drivers

The company’s domestic sales constituted 57% of total revenues, benefiting from strong demand, while export markets faced challenges. Recent strategic acquisitions, including Jayansree Pharma for ₹51.99 Cr and a chrome mining complex in South Africa, aim to broaden operational capabilities.

### Business Developments

The barium chemicals segment achieved its highest PAT in 12 quarters. Performance was bolstered by process enhancements and a diversified product mix, despite profitability challenges due to rising input costs and one-time expenses from acquisitions.

### Market Position and Competitive Advantage

Vishnu Chemicals maintains a strong position in the chromium and barium chemicals market, leveraging operational resilience and a flexible product mix. A solid balance sheet, with a debt-to-equity ratio of 0.45, positions the company for strategic investments.

### Investor Implications

Overall, the company’s strategic growth initiatives and robust domestic performance present a positive outlook, although investors should be mindful of ongoing cost challenges affecting profitability.